Welcome to our dedicated page for BCSS SEC filings (Ticker: BCSS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on BCSS's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into BCSS's regulatory disclosures and financial reporting.
Bain Capital GSS Investment Sponsor LLC filed a Schedule 13G reporting beneficial ownership of 12,370,000 Class A Ordinary Shares of Bain Capital GSS Investment Corp. (BCSS), representing 21.18% of the class as of the event date 10/01/2025. The reporting person has sole voting and sole dispositive power over all 12,370,000 shares.
The stake includes 11,470,000 Class B founder shares that are automatically convertible into Class A as described in the issuer’s Form S-1, and 900,000 private placement units that include 900,000 Class A shares. The reporting person is organized in the Cayman Islands.
Bain Capital GSS Investment Corp. (BCSS) completed its IPO, selling 46,000,000 units at $10.00 per unit. Each unit includes one Class A ordinary share and one-fifth of a redeemable warrant; each whole warrant is exercisable for one Class A ordinary share at an exercise price of $11.50, subject to adjustment.
The sponsor purchased 900,000 private placement units at $10.00 per unit, each with one Class A share and one-fifth of a non-redeemable warrant with the same $11.50 exercise price. Aggregate Offering Proceeds of $460,000,000 were placed in a trust account with Continental Stock Transfer & Trust Company as trustee.
Funds in the trust may be accessed upon the earliest of the completion of the initial business combination, redemption if no business combination is completed within 24 months from the IPO closing (or 27 months if a letter of intent has been executed), or certain shareholder-approved charter amendments relating to redemption rights. An audited balance sheet as of October 1, 2025 reflecting the proceeds is included as an exhibit.
